… European Guideline for the Management of Anogenital Warts. It provides guidance for best
practice in the care of patients with anogenital warts … the anogenital wart treatment guidelines …

… European guidelines for the management of anogenital warts. Methods We performed a
systematic review of randomized controlled trials for anogenital warts… The IUSTI Europe Editorial …

… HPV) genotypes 6 and 11 in >95% of cases.(5) Multiple HPV types may be present in anogenital
warts … coinfection, but there is no evidence that high risk HPV types cause genital warts. …

… to manage anogenital warts (AGWs). However, no hierarchy of treatments is provided in the
latest European and … the efficacy and safety of local treatments for the management of AGWs. …

… The IUSTI Europe Editorial Board reviewed the draft guideline which was also posted on
the web for comments which we incorporated into the final version of the guideline. …

… Anogenital warts (AGWs) are benign epithelial skin lesions that are predominantly caused
by the human papillomavirus (HPV types 6 and 11), but are sometimes associated with other …

… General Principles of Treatment Up to date, no definitive and etiological treatment has been
found for cutaneous and genital warts. Our approach is limited to tissue destructive therapies …

… treatments reported in at least 1 parallel treatment group). Our analysis covered a large …
only 2 treatment groups. Our systematic review included RCTs of anogenital wart treatments …

… While usually benign (genital warts), human papilloma virus (HPV) infections with high-risk …
Treatment recommendations are summarized in the guidelines of IUSTI Europe and the …

… of HPV 6 and 11 in the UK has fallen in vaccinated groups with an associated 35% decline in
the number of genital warts … treatment of external perianal warts on an off-license basis (1B) …